251 related articles for article (PubMed ID: 9066236)
1. DNA flow cytometric measurements in breast cancer: a review of the instrumentation principles and clinical significance.
Berho M; Viciana AL; Poppiti RJ; Ruiz P
J Fla Med Assoc; 1997 Feb; 84(2):104-10. PubMed ID: 9066236
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.
Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD
Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277
[TBL] [Abstract][Full Text] [Related]
3. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence-based analysis of DNA ploidy and cell proliferation within fine-needle samplings of breast tumors: a new approach using automated image cytometry.
Truong K; Vielh P; Malfoy B; Klijanienko J; Dutrillaux B; Bourgeois CA
Cancer; 1998 Oct; 84(5):309-16. PubMed ID: 9801206
[TBL] [Abstract][Full Text] [Related]
5. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
[TBL] [Abstract][Full Text] [Related]
6. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
[TBL] [Abstract][Full Text] [Related]
7. DNA and cell cycle analysis as prognostic indicators in breast tumors revisited.
Bagwell CB; Clark GM; Spyratos F; Chassevent A; Bendahl PO; Stål O; Killander D; Jourdan ML; Romain S; Hunsberger B; Wright S; Baldetorp B
Clin Lab Med; 2001 Dec; 21(4):875-95, x. PubMed ID: 11770293
[TBL] [Abstract][Full Text] [Related]
8. [Flow cytometric analysis of DNA ploidy pattern in breast cancer: malignant potential and prognostic implication].
Hara S; Tomita M
Nihon Rinsho; 1992 Oct; 50(10):2444-9. PubMed ID: 1447815
[TBL] [Abstract][Full Text] [Related]
9. [DNA flow cytrometry in solid tumors].
Pinto AE; Fonseca I; Soares J
Acta Med Port; 2002; 15(2):133-42. PubMed ID: 15524158
[TBL] [Abstract][Full Text] [Related]
10. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of flow cytometry for metastatic potential in breast cancer.
Schmidt H; Wei JP; Yeh KA
Am Surg; 1999 May; 65(5):434-8. PubMed ID: 10231212
[TBL] [Abstract][Full Text] [Related]
12. S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study.
Chassevent A; Jourdan ML; Romain S; Descotes F; Colonna M; Martin PM; Bolla M; Spyratos F
Clin Cancer Res; 2001 Apr; 7(4):909-17. PubMed ID: 11309341
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.
Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J
Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729
[TBL] [Abstract][Full Text] [Related]
14. Bivariate RNA and DNA content analysis in breast carcinoma: biological significance of RNA content.
El-Naggar AK; Kemp BL; Sneige N; Hurr KG; Steck K; Tu ZN; Fritsche HA; Singletary SE; Balch CM
Clin Cancer Res; 1996 Feb; 2(2):419-26. PubMed ID: 9816186
[TBL] [Abstract][Full Text] [Related]
15. [DNA analysis of breast cancer].
Ohuchi N; Mori S
Gan To Kagaku Ryoho; 1991 Jan; 18(1):30-6. PubMed ID: 1987899
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric analysis of DNA ploidy and S-phase fraction in breast cancer using cells obtained by ex vivo fine-needle aspiration: an optimal method for sample collection.
Eliasen CA; Opitz LM; Vamvakas EC; Espiritu EC; Marsh ER; Roses DF; Harris MN; Feiner HD
Mod Pathol; 1991 Mar; 4(2):196-200. PubMed ID: 2047382
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
[TBL] [Abstract][Full Text] [Related]
18. Reproducibility of semi-automated cell cycle analysis of flow cytometric DNA-histograms of fresh breast cancer material.
Bergers E; van Diest PJ; Baak JP
Anal Cell Pathol; 1995 Jan; 8(1):1-13. PubMed ID: 7734408
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric DNA analysis of breast cancer by two colour method using cytokeratin labeling for identification of tumour cells.
Kimmig R; Spelsberg H; Kapsner T; Untch M; Hepp H
Anal Cell Pathol; 1994 Oct; 7(3):205-15. PubMed ID: 7531483
[TBL] [Abstract][Full Text] [Related]
20. DNA flow cytometry in solid tumors: practical aspects and clinical applications.
Dressler LG; Bartow SA
Semin Diagn Pathol; 1989 Feb; 6(1):55-82. PubMed ID: 2645625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
